Julie Scher

Julie possesses a proven track record of success in complex civil litigation matters.  She leverages her experience working at some of the nation’s largest law firms in both Los Angeles and Boston to help clients craft aggressive yet practical litigation strategies to resolve a wide range of business and real estate disputes.

Concentrating on complex commercial litigation and internal investigations, Julie represents a variety of clients across an array of businesses, including the commercial real estate, life sciences, and healthcare industries.  She regularly represents commercial real estate landlords in a variety of real estate-related disputes and advises real estate owners, lenders, and court-appointed receivers in connection with workouts, bankruptcies, and other high-stakes disposition strategies. 

Prior to joining Harvest, Julie practiced at Norton Rose Fulbright where she focused on class action litigation for unfair competition and false advertising claims and defended major retail clients in Proposition 65 actions.  She was also a member of the Business Litigation & Dispute Resolution practice team at Foley & Lardner LLP.  There she represented former stockholders of a company in an earnout dispute, assisted with the due diligence in the purchase of a professional sports team, litigated a variety of business disputes, and was active in the firm’s pro bono efforts, including successfully trying two cases as lead trial counsel.  Early in her career, she served as a legal intern for the Boston Red Sox.

Julie is admitted to practice in California, Massachusetts, and before multiple United States District Courts, including the Northern, Central, and Southern Districts of California, and the District of Massachusetts.

Notable Deals

• Represented olive oil manufacturers, as defendants, in a major class-action lawsuit.
• Represented major retailers including Target, Amazon, and TJ Maxx in Proposition 65 cases.
• Represented a state housing agency in complex contract disputes.
• Represented the pharmaceutical manufacturer of a radiotherapeutic drug in an intellectual property dispute involving European Union patent development rights.
• Represented the former stockholders of a cyber technology company in a dispute over a $40 million earnout.